Hexacyclonate
| 200px | |
| Hexacyclonate
| |
| Systematic (IUPAC) name | |
| 2-[1-(hydroxymethyl)cyclohexyl]acetic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C9H16O3 |
| Mol. mass | 172.222 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Hexacyclonate (Gevilon) is a stimulant drug. It was previously used for the treatment of alcoholism[1] and for increasing motivation in elderly patients,[2] but is now mainly used for the treatment of hyperlipoproteinaemia.[3][4]
References
- ↑ Chesrow EJ, Sabatini R, Musci JP, Kaplitze SE, Marquardt GH. Adjunctive treatment of the chronic alcoholic with hexacyclonate sodium. Illinois Medical Journal. 1962 May;121:546-8.
- ↑ Morrison BO. Pharmaco-motivation of the geriatric patient: a preliminary report on hexacyclonate. Journal of the Louisiana State Medical Society. 1962 Jan;114:23-6.
- ↑ Milewicz A, Plamieniak Z, Bohdanowicz-Pawlak A. Therapeutic effect of gevilon in patients with hyperlipoproteinaemia. Polish Journal of Medicine and Pharmacy. 1992 Apr-Jun;24(2):91-5.
- ↑ Gazdikova K, Korecka P, Springer V, Gazdik F. Pharmacoeconomic aspects of patients treated by hemodialysis. Bratislavske Lekarske Listy. 2003;104(10):329-34.
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies